Active ingredient groups and their key target combinations for the treatment of UC

Abstract

The present invention belongs to the field of medical technology and specifically relates to an active ingredient group for treating UC. An active ingredient group for treating UC, characterized in that it uses an active ingredient group to act on key target combination of UC, and prevents and treats UC by regulating tryptophan metabolism, glycerolphospholipid metabolism, and linoleic acid metabolism. The active ingredient group for treating UC provided in this application can effectively prevent and treat UC by regulating tryptophan metabolism, glycerolphospholipid metabolism and linoleic acid metabolism by establishing strong combination between the active ingredient group and the key target combination of UC. This application also discloses the biomarkers for the diagnosis and treatment of UC.

Dependencies are inferred from the claim text.